secwatch.observer — SEC 8-K summary
======================================

Issuer:     COOPER COMPANIES, INC. (COO)
CIK:        0000711404
Form:       8-K
Filed at:   2021-12-02T23:59:59+00:00
Accession:  0000711404-21-000030
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CooperCompanies reports record FY2021 revenue; Q4 revenue up 11% to $759.1M
---------------------------------------------------------------------------

- Q4 revenue $759.1M (+11% YoY); GAAP EPS $2.21 (+35%); Non-GAAP EPS $3.28 (+4%)
- FY2021 revenue $2,922.5M (+20%); Non-GAAP EPS $13.24 (+37%)
- CooperVision rev $564.8M (+12%); CooperSurgical rev $194.3M (+11%)
- FY2022 guidance: rev $3,032-3,090M (+6-8% cc); Non-GAAP EPS $13.60-14.00
- Generate Life Sciences acquisition (announced Nov 10) not included in guidance

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/711404/000071140421000030/0000711404-21-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/711404/000071140421000030/coo-20211202.htm
  HTML page:      https://secwatch.observer/filing/0000711404-21-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer